Features of Matrix Metalloproteinases MMP2, MMP3, and MMP9 of Regulatory-Region Polymorphism in Patients with Uterine Fibroids

Dysregulation of the extracellular matrix components synthesis contributes to the formation and growth of uterine fibroids. Changes of collagen metabolism in connective tissue may be associated with polymorphism of matrix metalloproteinase (MMP) genes. The aim of the study was to analyze of the association of regulatory regions of matrix metalloproteinase MMP2 (rs243865), MMP3 (rs3025058), and MMP9 (rs3918242) genes with the development of leiomyoma, its histological form, and several concomitant gynecological diseases. A clinical study of 69 patients (23–54 years old) with myomas was conducted. According to the anamnesis, 57.9% of patients had given birth, 46.4% of women had had an artificial interruption of pregnancy, and 15.9% of women had had endometriosis. In histological examination, in 48.14% of cases, the nodes corresponded to the phenotype of simple fibroids with a large proportion of fibrous tissue, while 51.6% corresponded to the phenotype of proliferating fibroids. The comparison group is represented by a random population sample of women from Western Siberia. A total of 183 women without pronounced gynecological diseases were examined. MMP2-1306 C/T polymorphism was analyzed by TaqMan, MMP3-1171 5A/6A, and MMP9-1562 C/T by restriction fragment length polymorphism method. The genotype frequencies of the analyzed genes did not significantly differ between the groups. The complex genotype MMP2-1306CC:MMP3-11715A6A:MMP9-1562CT was decreased in women with myoma relative to the persons of the comparison group. In endometriosis patients, the MMP9-1562CC genotype was reduced and heterozygosity was increased relative to patients without endometriosis. The frequency of the MMP2-1306CC:MMP9-1562CT complex genotype is significantly higher in women who gave birth than in women who did not give birth. Differences in frequencies of complex genotypes between histological variants of leiomyoma were revealed. The results of the study show the significance of polymorphism effect of the regulatory regions of the MMP genes in the development of leiomyoma and nature of disease progression. Similar content being viewed by others

Baptista, I., Xia, P. and Singh, B., Matrix metalloproteinases as biomarkers of endometriosis and the role of progesterone receptors, J. Sci. Techn. Res., 2019, vol. 21, p. 16044. https://doi.org/10.26717/BJSTR.2019.21.003636 Bartnykait, A., Savukaityt, A., Bekampyte, J., Ugenskiene, R., Laukaitien, D., Korobeinikova E., Gudaitiene, J., and Juozaityte, E., The role of matrix metalloproteinase single-nucleotide polymorphisms in the clinicopathological properties of breast cancer, Biomedicines, 2022, vol. 10, p. 1891. https://doi.org/10.3390/biomedicines10081891 Botía, C.P., Camarasa, S.C., Baixauli, F.R. and Sanchez, A.C., Uterine fibroids: Understanding their origins to better understand their future treatments, J. Tumor Res., 2017, vol. 3, p. 130. https://doi.org/10.35248/2684-1258.17.3.130 Chazan, F.L., Bonetti, T.C.S., Gomes, M.T.V., Fornazari, V.A.V., Girão, M.J.B.C., and Bonduki, C.E., Extracellular matrix metalloproteinase expression in endometrial tissue after arterial embolization of myomas, Clinics (Sao Paulo), 2021, vol. 76, p. e2145. https://doi.org/10.6061/clinics/2021/e2145 Courtoy, G.E., Henriet, P., Marbaix, E., de Codt, M., Luyckx, M., Donnez, J., and Dolmans M.M., Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment, J. Clin. Endocrinol. Metab., 2018, vol. 103, p. 1566. https://doi.org/10.1210/jc.2017-02295 Du, J.B., Zhang, W., Li, N., Jiang, H., Liu, Y., Gao, J., Chen, S.T., Cong, H.L., and Wei, Y.L., Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population, J. Int. Med. Res., 2020, vol. 48, p. 300060519827145. https://doi.org/10.1177/0300060519827145 Governini, L., Marrocco, C., Semplici, B., Pavone, V., Belmonte, G., Luisi, S., Petraglia, F., Luddi, A., and Piomboni, P., Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas, Fertil. Steril., 2021, vol. 116, p. 1404. https://doi.org/10.1016/j.fertnstert.2021.06.023 Islam, M.S., Ciavattini, A., Petraglia, F., Castellucci, M., and Ciarmela, P., Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics, Hum. Reprod. Update, 2018, vol. 24, p. 59. https://doi.org/10.1093/humupd/dmx032 Kamel, M., Wagih, M., Kilic, G.S., Diaz-Arrastia, C.R., Baraka, M.A., and Salama, S.A., Overhydroxylation of lysine of collagen increases uterine fibroids proliferation: roles of lysyl hydroxylases, lysyl oxidases, and matrix metalloproteinases, Biomed. Res. Int., 2017, vol. 2017, p. 5316845. https://doi.org/10.1155/2017/5316845 Kang, S., Wang, Y., Zhang, J.H., Jin, X., Fang, S.M., and Li, Y., Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis, Zhonghua Fu Chan Ke Za Zhi., 2005, vol. 40, p. 601. Kononenko, N.M., Significance of gene polymorphism in the development of uterus leiomyoma, Biol. Markers Fundam. Clin. Med., 2019, vol. 3, p. 58. https://doi.org/10.29256/v.03.01.2019.escbm01-89 Onishi, K., Zhang, J., Blanck, J., and Singh, B., A systematic review of matrix metalloproteinases as potential biomarkers for uterine fibroids, F&S Rev., 2022, vol. 3, p. 227. https://doi.org/10.1016/j.xfnr.2022.07.003 Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J.C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M.A., and Alvarez-Sánchez, M.E., Role of matrix metalloproteinases in angiogenesis and cancer, Front. Oncol., 2019, vol. 9, p. 1370. https://doi.org/10.3389/fonc.2019.01370 Saare, M., Lamp, M., Kaart, T., Karro, H., Kadastik, U., Metspalu, A., Peters, M., and Salumets, A., Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis, Fertil. Steril., 2010, vol. 94, p. 1560. https://doi.org/10.1016/j.fertnstert.2009.12.024 Savchenko, I.N. and Garbuzova, V.Y., Role of single-nucleotide polymorphism C-1562T of the matrix metaloproteinaza-9 gene in the development of leiomyoma in women with cervical pathology, Georgian Med. News, 2015, vol. 239, p. 18. Xin, L., Hou, Q., Xiong, Q.I., and Ding, X., Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: a systematic review and meta-analysis, Biomed. Rep., 2015 vol. 3, p. 559. https://doi.org/10.3892/br.2015.447 Yarmolinskaya, M.I., Ivashchenko, T.E., Kusevits-kaya, M.B., and Osinovskaya, N.S., Analysis of MMP1 gene polymorphism depending on clinical features of uterine myoma, Probl. Reprod., 2020, vol. 26, p. 73. https://doi.org/10.17116/repro20202601173 Zafrakas, M., Kοtronis, K., Papasozomenou, P., Eskitzis, P., and Grimbizis, G., Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal, Clin. Exp. Obstet. Gynecol., 2020, vol. 47, p. 147. https://doi.org/10.31083/j.ceog.2020.02.5140 Funding This study was performed within the framework of a state order to the Research Institute of Clinical and Experimental Lymрhology, Branch of the Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences (no. 122022800132-1), and a state order to Novosibirsk State Medical University, Ministry of Health of the Russian Federation (no. 121021700349-8). Author information Authors and Affiliations Corresponding author Ethics declarations Conflict of interest. The authors declare that they have no conflicts of interest. Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee of the Research Institute of Clinical and Experimental Lymрhology, Branch of the Institute of Cytology and Genetics, Novosibirsk State Regional Clinical Hospital (protocol no. 3 of November 28, 2013), and Novosibirsk State Medical University (protocol no. 107 of May 31, 2018). Informed consent was obtained from all individual participants involved in the study. Additional information Translated by M. Novikova Publisher’s Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions About this article Cite this article Shevchenko, A.V., Prokof’ev, V.F., Konenkov, V.I. et al. Features of Matrix Metalloproteinases MMP2, MMP3, and MMP9 of Regulatory-Region Polymorphism in Patients with Uterine Fibroids. Cell Tiss. Biol. 17, 699–705 (2023). https://doi.org/10.1134/S1990519X23060135 Received: Revised: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1134/S1990519X23060135